Mindfulness meditation found to be as effective as antidepressants to prevent depression relapse

Dec 06, 2010

A new study from the Centre for Addiction and Mental Health (CAMH) has found that mindfulness-based cognitive therapy--using meditation—provides equivalent protection against depressive relapse as traditional antidepressant medication.

The study published in the current issue of the Archives of General Psychiatry compared the effectiveness of pharmacotherapy with mindfulness-based cognitive therapy (MBCT) by studying people who were initially treated with an antidepressant and then, either stopped taking the medication in order to receive MBCT, or continued taking medication for 18 months.

"With the growing recognition that major depression is a recurrent disorder, patients need treatment options for preventing depression from returning to their lives." said Dr. Zindel Segal, Head of the Cognitive Behaviour Therapy Clinic in the Clinical Research Department at CAMH.

"Data from the community suggest that many depressed patients discontinue antidepressant medication far too soon, either because of side effect burden, or an unwillingness to take medicine for years. Mindfulness-based cognitive therapy is a non pharmacological approach that teaches skills in emotion regulation so that patients can monitor possible relapse triggers as well as adopt lifestyle changes conducive to sustaining mood balance.

Study participants who were diagnosed with major depressive disorder were all treated with an antidepressant until their symptoms remitted. They were then randomly assigned to come off their medication and receive MBCT; come off their medication and receive a placebo; or stay on their medication. The novelty of this design permits comparing the effectiveness of sequencing pharmacological and psychological treatments versus maintaining the same treatment – antidepressants - over time

Participants in MBCT attended 8 weekly group sessions and practiced mindfulness as part of daily homework assignments. Clinical assessments were conducted at regular intervals, and over an 18 month period, relapse rates for patients in the MBCT group did not differ from patients receiving antidepressants (both in the 30% range), whereas patients receiving placebo relapsed at a significantly higher rate (70%).

"The real world implications of these findings bear directly on the front line treatment of depression. For that sizeable group of patients who are unwilling or unable to tolerate maintenance antidepressant treatment, MBCT offers equal protection from relapse,".said Dr. Zindel Segal. "Sequential intervention-- offering pharmacological and psychological interventions-- may keep more patients in treatment and thereby reduce the high risk of recurrence that is characteristic of this disorder.

Explore further: Ethical behavior can be contagious, study says

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Ethical behavior can be contagious, study says

10 minutes ago

A new study from Penn State Smeal College of Business faculty members Steven Huddart and Hong Qu examines the power of social influence on managers' ethical behavior. The Department of Accounting researchers find that managers ...

Predicting the future course of psychotic illness

1 hour ago

University of Adelaide psychiatry researchers have developed a model that could help to predict a patient's likelihood of a good outcome from treatment – from their very first psychotic episode.

Boys will be boys? Yes, neuroscience now shows

11 hours ago

If you've ever tried to warn teenagers of the consequences of risky behavior - only to have them sigh and roll their eyes - don't blame them. Blame their brain anatomy.

Depression increasing across the country

15 hours ago

A study by San Diego State University psychology professor Jean M. Twenge shows Americans are more depressed now than they have been in decades.

User comments : 0